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ABSTRACT 
Leptospirosis infection is commonly determined by positive response antibody in 
microaglutination test (MAT). The test requires panels of Leptospira from complete serovars and 
uses infectious Leptospira, which is subcultured weekly. Accordingly, other alternative serological 
tests are developed for MAT. One of them is ELISA using recombinant LipL32 protein (rLipL32). 
High sensitivity and specificity of ELISA rLipL32 for Leptospirosis detection in bovine and canine 
has been reported previously. In this study, we produced antibody to rLipL32 protein with high 
titre. Results on western blotting and ELISA showed anti-LipL32 antibody was highly binding to 
rLipL32 protein. In contrast, MAT results for LipL32 antibody was found to be negative response, 
indicating that titre antibody to LipL32 does not positively correlate to MAT. 
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INTRODUCTION 
Diagnosis of Leptospirosis can be determined by detection of antigen using isolation 
of the organism but it is difficult to  apply (Cousins et al. 1985; Levett 2001). As a result, 
OIE (2013) stated that serological microaglutination test (MAT) is  the gold standard to 
diagnose Leptospirosis. However, the MAT has many disadvantages such as: technical 
difficulties, time consuming and highly contagious agents (Bajani et al. 2003). Another 
serological test such as ELISA has been developed to overcome this problem by using 
antigen from whole cell Leptospira or outer membrane protein (OIE 2013). 
Protein LipL32 is known as one of Leptospira major outer membrane protein and it is 
believed as a potential antigen for serological test. It is exposed in the surface of 
Leptospira cell and can be found as much as 40,000 copies for each cell (Cullen et al. 
2005; Malmström et al. 2009). Several studies also reported that LipL32 is an 
immunodominant protein and plays important role in Leptospirosis infections (Haake et al. 
2000; Chaemchuen et al. 2011). 
Indonesia is an endemic country for Leptospirosis and application of ELISA LipL32 
could be useful as an alternative MAT for diagnostic test. Studies conducted previously by 
Bomfim et al. (2005) and Dey et al. (2004) reported high sensitivity and accuracy for 
ELISA LipL32 in bovine and canine, respectively, compared to MAT. However, in our 
preliminary study using 13 serum sample showed inconsistent results between MAT and 
ELISA LipL32 for detection of Leptospira in bovine (Sumarningsih et al. 2016). The 
inconsistent results of the previous study were: some positive sera on MAT showed 
negative responsense on ELISA LipL32 and some negative sera on MAT were found to be 
positive on ELISA LipL32. To investigate this contradictory results, further study are 
required by producing serum anti rLipL32 in rabbit and bovine, and then analyse the 
correlation between the antibody titre to LipL32 and MAT. 
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MATERIAL AND METHODS 
Recombinant LipL32 used to produced antibody to rLipL32 in rabbit and bovine were 
the result from the previous study conducted by Sumarningsih et.al. (2016). Analysis of 
antibody titre in this study was performed based on MAT, western blotting, and ELISA 
rLipL32 techniques. 
Production of antibody to rLipL32 protein 
Antibody to LipL32 were produced in rabbit and bovine according to previous study 
(Yang et al. 2002). One New Zealand rabbit age 10-12 weeks and one bull (Sumbawa male 
bovine) age 10 months were used to produce antibody to LipL32. Before being imunised, 
rabbit and bovine sera were collected and tested using MAT to confirm that those animals 
were negative from Leptospirosis infection. For immunisation, a rabbit was injected 
intramusculary with 0.4 mg of rLipL32 in complete Freund’s adjuvant (Sigma-Aldrich, 
UK) for first immunisation, followed by 0.4 mg with incomplete Freund’s adjuvant 
(Sigma-Aldrich, UK) as a second and third immunisation, at two week intervals. Sera were 
collected prior to each immunisation and two weeks after the third immunisation. 
For bovine immunisation, 1 mg of recombinant protein was mixed with Montanide 
ISA 70 M VG (SEPPIC) as adjuvant and used for immunisation. Bovine anti LipL32 
serum was collected for LipL32 titre analysis. Similar procedure for MAT was conducted 
as described by Sumarningsih et al. (2016) to determine the titre of all sera collected in this 
study. 
Western blotting 
Western blotting was carried out according to the previous study with few 
modification on the blocking buffer and serum dilution (Seenichamy et al. 2014). In brief, 
antigen rLipL32 protein was transferred into nitrocellulose membrane, and then blocked 
with 4% goat normal serum in PBS. The membrane was incubated with rabbit or bovine 
serum and followed by incubation with 1/5000 HRP coupled to goat-anti-rabbit IgG or 
goat-anti-bovine IgG, respectively. Antigen-antibody binding was detected by 3-
3’diaminobenzidine tetrahydrochloride (DAB) (Sigma Aldrich Pty Ltd, Castle Hill, NSW). 
Enzyme linked-immunosorbent assay (ELISA) 
ELISA was performed using similar procedure to Bomfim et al. (2005) with few 
modifications on antigen concentration for coating and dilution of primary and secondary 
antibody. The amount of rLipL32 protein used for coating was 250 ng/well, after being 
blocked with blocking buffer (PBS-T 0.05% + 5% normal goat serum), NUNC maxisorb 
plate was incubated with primary antibody (50 μl of series of two fold dilution of rabbit or 
bovine serum started at 1/200), and continued with secondary antibody (50 μl of 1/5000 
diluted HRP-goat-anti-rabbit IgGor goat-anti-bovine IgG). At the end, the antigen-
antibody binding was detected by adding 50 μl of ABTS. After 15 minutes, the optical 
density (OD) was determined at a wavelength of 420 nm (OD420) using an ELISA reader. 
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RESULTS AND DISCUSSION 
Western blotting of anti rLipL32 serum 
Anti LipL32 serum were produced in rabbit and bovine using recombinant LipL32 
protein (rLipL32). The functional analysis of antigenicity for this rLipL32 was analysed by 
western blotting and ELISA. Western blotting demonstrated that rLipL32 were highly 
binding to serum from rabbit immunized with rLipL32 after second and third 
immunisation (lane 2 and 3) but not for serum collected from the first immunisation and 
preimmune (Figure 1). Antigen-antibody binding was also found in serum from bovine 
immunized with rLipL32 (lane 6) but preimmune bovine serum could not response to 
LipL32 protein. These results demonstrated that the rLipL32 could induce high antibody 
response in rabbit and bovine, indicating the high antigenicity and immunogenicity of 
protein LipL32, as reported from the preliminary study which showed that rLipL32 protein 
could detect serum from bovine positive MAT (Sumarningsih et al. 2016). 
 
Figure 1. Western blotting of rLipL32 proteins. rLipL32 was subjected to 10% SDS PAGE, 
transferred to nitrocellulose membrane and incubated with 1/200 rabbit polyclonal 
antibody anti rLipL32 2wkPI1 (lane 1), 2wkPI2 (lane 2), 2wkPI3 (lane 3) and 1/200 
bovine polyclonal antibody anti rLipL32; Normal rabbit (lane 4) and normal bovine 
(lane 5) sera were used as negative control 
Enzyme linked-immunosorbent assay (ELISA) of anti rLipL32 serum 
Upon the preliminary study, it was determined that 5 μg/ml was the maximum 
concentration for rLipL32 to binding into microtiter plates. This concentration was then 
used for coating of rLipL32 protein. Figure 2 showed that the titre of antibody response to 
LipL32 remained normal in rabbit until two weeks after the first immunisation, but then 
increased significantly after the second and the third immunisation. For bovine serum, 
immunisation was performed once due to the limitation of LipL32 product. However, the 
titre of antibody to LipL32 was significantly high. The difference on method used for 
rabbit and bovine was the amount of antigen LipL32 applied in serum production. For 
bovine, it used 1 mg of LipL32 protein, while rabbit only used 0.4 mg of LipL32. 
Considered the size of rabbit compared to bovine as an experimental animal, the amount of 
LipL32 used for immunisation should be not the reason for difference antibody titre. 
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Another explanation was different adjuvant used for rabbit and bovine. In bovine, 
Montanide ISA 70 M VG (SEPPIC) was used as an adjuvant, but in rabbit it was both 
complete and incomplete Freund’s adjuvant (Sigma-Aldrich, UK). The further 
investigation was required to determine whether these two different adjuvant affecting the 
antibody titre in production of serum anti rLipL32. 
 
 
 
Figure 2. (A) LipL32 antibody titre in rabbit serum obtained from immunisation with 
recombinant LipL32 protein at two weeks after the first immunisation (2wk PI1), two 
weeks after the second immunisation (2wk PI2) and two weeks after  the third 
immunisation (2wk PI3); (B) LipL32 antibody titre in bovine serum obtained from 
immunisation with recombinant LipL32 protein at three months after immunisation 
(3months PI); Serum from rabbit and bovine before immunisation (normal) was 
included as negative control; Serum dilution 1 to 8 represents two folds dilution for 
1/200 to 1/25600 
The correlation between MAT, western blotting and ELISA results was showed in 
Table 1, illustrating serum anti LipL32 produced in rabbit and bovine had very high titre, 
more than 25600, to recombinant LipL32 protein and it was confirmed by western blotting 
and ELISA. However, the results in MAT for all sera were negative. This finding indicated 
that there is no positive correlation between titre antibody to LipL32 and MAT. It is 
contradictory with previous study which reported antibody response in ELISA LipL32 was 
highly correlate to MAT (Flannery et al. 2001; Dey et al. 2004; Bomfim et al. 2005). 
(A) 
(B) 
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Table 1. Summary of MAT, Western blotting and ELISA results for serum anti rLipL32  
Serum Time of collection MAT 
Antibody titre to rLipL32 protein 
Western blotting ELISA 
Rabbit Preimmune Negative Negative Negative 
 2wk PI-1 Negative Negative Negative 
 2wk PI-2 Negative Positive >25600 
 2wk PI-3 Negative Positive >25600 
Bovine Preimmune Negative Negative Negative 
 3months PI-1 Negative Positive >25600 
Correlation between antibody response to LipL32 (ELISA and western blotting) and 
MAT in the study demonstrated that antibody to LipL32 and MAT are incomparable. In 
Leptospira infection, antibody to bacterial surface proteins (antigens) plays important role 
to prevent attachment of the bacterium to the host cell. Pinne and Haake mentioned that 
LipL32 is entirely or almost entirely located in the subsurface of Leptospira (Pinne & 
Haake 2013). Antigen used in MAT was intact cell of Leptospira and it might be a 
majority of LipL32 exposed in the surface. Therefore, comparison of ELISA LipL32 could 
be better using other serological tests such as disrupted whole Leptospira cell as an 
antigen. 
CONCLUSION 
Serum anti Lip32 was successfully produced in both rabbit and bovine with high titre 
more than 25600 in ELISA LipL32, but these serum were found to be negative response in 
MAT. It is indicated that there is no positive correlation between antibody titre to LipL32 
and MAT. 
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